Eulerpool News

Allogene Therapeutics Eulerpool News

Allogene Therapeutics Ειδήσεις Μετοχών

Το Allogene Therapeutics παρακολουθείται από πολλούς δημοσιογράφους και επενδυτές σε όλον τον κόσμο. Τα πιο πρόσφατα νέα Allogene Therapeutics τα συγκεντρώνουμε εδώ.

• 5 Ιουλίου ·

  SeekingAlpha
  Caribou's Allogeneic CAR-T Therapy: Analyzing HLA Matching And CB-010's Clinical Performance
• 1 Ιουλίου ·

  Yahoo
  Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL)
• 27 Ιουνίου ·

  Yahoo
  With 56% institutional ownership, Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a favorite amongst the big guns
• 27 Ιουνίου ·

  Yahoo
  Allogene Therapeutics, Inc. (ALLO): Are Analysts Bullish About the Potential of This Small-Cap Stock?
• 20 Ιουνίου ·

  Yahoo
  Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse
• 20 Ιουνίου ·

  Thefly.com
  Allogene Therapeutics initiates Phase 2 cema-cel trial
• 17 Ιουνίου ·

  TipRanks
  Piper Sandler Remains a Buy on Allogene Therapeutics (ALLO)
• 13 Ιουνίου ·

  Thefly.com
  Allogene Therapeutics participates in a conference call with JPMorgan
• 12 Ιουνίου ·

  Yahoo
  Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound?
• 12 Ιουνίου ·

  SeekingAlpha
  Allogene: Two End Of 2024 Data Readouts With Improved Allogeneic CAR-T Products